Preventing hepatitis B virus reactivation following immunosuppressive therapy.
Davis
J
J
D024882:Drug Resistance, Viral / Q000276:immunology; D006509:Hepatitis B / Q000276:immunology* / Q000517:prevention & control* / Q000628:therapy; D006515:Hepatitis B virus / Q000276:immunology*; D006801:Humans; D007165:Immunosuppression Therapy / Q000009:adverse effects* / Q000379:methods; D007166:Immunosuppressive Agents / Q000009:adverse effects; D033581:Stem Cell Transplantation / Q000009:adverse effects
D007166:Immunosuppressive Agents